Norway, July 1 -- Lifecare ASA (LIFE), a medtech company developing next-generation Continuous Glucose Monitoring (CGM) technology for diabetes management, today announces the completion of initial testing of electronics developed for our Continuous Glucose Monitoring implant.This initial testing of the electronics for use in our implant with wireless communication includes electromagnetic compatibility (EMC) and Radio Frequency (Rf). The first EMC tests of electronics were completed by ShortLink Compliance AB and reported to Lifecare.EMC testing checks whether the electronics used in our implant and read-out unit will function correctly in the real world, where it will be surrounded by things like mobile phones, Wi-Fi, and other wireless t...